Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Organic selenium for breast cancer-related lymphedema
IRCT20131009014957N12Phase 3Completed
- Sponsor
- Tabriz University of Medical Sciences
- Start
- May 2022
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of selenium in breast cancer-related lymphedema (BCRL), sponsored by Tabriz University of Medical Sciences. Started May 2022; status: completed.
02
Drugs
selenium
03
Conditions
breast cancer-related lymphedema (BCRL)
Beyond the preview
Go deeper on IRCT20131009014957N12.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131009014957N12.